A phase I study of HYB2055 in patients (pts) with advanced solid malignancies

被引：0
|
作者：
Hwang, JJ
Park, S
Amin, A
Martin, RR
Sullivan, T
Burns, T
Agrawal, S
Waxdal, MJ
Malik, S
Marshall, JL
机构：
[1] Georgetown Univ, Med Ctr, Washington, DC 20057 USA
[2] Hybridon Inc, Cambridge, MA USA
[3] Fast Syst, Gaithersburg, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3111
引用
收藏
页码：222S / 222S
页数：1
相关论文
共 50 条
  • [11] Phase I study of capecitabine (C) in combination with cisplatin (DDP) and irinotecan (IRI) in patients (pts) with advanced solid malignancies
    Sayar, H.
    Verschraegen, C. F.
    Smith, H.
    Rabinowitz, I.
    Lee, F. C.
    Shen, Z.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [12] A phase I study of the oral platinum agent satraplatin (S) in with capecitabine (C) in patients (pts) with advanced solid malignancies
    Wisinski, K.
    Mulcahy, M.
    Kuzel, T. M.
    Benson, A. B., III
    Agulnik, M.
    MacVicar, G. R.
    Desai, D.
    Yun, S.
    Petrone, M.
    Gradishar, W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [13] A PHASE I DOSE ESCALATION STUDY OF SUNITINIB (SU) IN COMBINATION WITH PEMETREXED (PEM) IN PATIENTS (PTS) WITH ADVANCED SOLID MALIGNANCIES
    Chow, L. Q. M.
    Jonker, D. J.
    Laurie, S. A.
    Call, J. A.
    Diab, S. G.
    McWilliam, M.
    Wang, E.
    Chao, R.
    Eckhardt, S. G.
    Camidge, D. R.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 159 - 159
  • [14] Sunitinib (SU) in combination with pemetrexed (P) in patients (pts) with advanced solid malignancies: A phase I dose escalation study
    Chow, L. Q.
    Jonker, D. J.
    Laurie, S. A.
    Call, J. A.
    Diab, S. G.
    Goss, G.
    McWilliam, M.
    Wang, E.
    Chao, R.
    Eckhardt, S. G.
    Camidge, D. R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [15] Phase I and pharmacokinetic study of VEGF Trap administered subcutaneously (sc) to patients (pts) with advanced solid malignancies.
    Dupont, J
    Schwartz, L
    Koutcher, J
    Spriggs, D
    Gordon, M
    Mendelson, D
    Murren, J
    Lucarelli, A
    Cedarbaum, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 197S - 197S
  • [16] A phase I dose finding study of E7080 in patients (pts) with advanced malignancies
    Glen, H.
    Boss, D.
    Evans, T. R.
    Roelvink, M.
    Saro, J. M.
    Bezodis, P.
    Copalu, W.
    Das, A.
    Crosswell, G.
    Schellens, J. H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [17] A phase I study of the heparanase inhibitor PI-88 given subcutaneously (sq) in patients (pts) with advanced solid malignancies
    Holden, S
    Basche, M
    O'Bryant, C
    Morrow, M
    Grolnic, S
    Persky, M
    Deem, C
    Roberts, K
    Ribbons, K
    Eckhardt, S
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 : S74 - S75
  • [18] A phase I study of the heparanase inhibitor: PI-88 and weekly docetaxel in patients (PTS) with advanced solid malignancies.
    Raj, SKS
    Basche, M
    Gore, L
    Grolnic, S
    Hunt, J
    O'Bryant, CL
    Morrow, M
    Creese, B
    Kangas, M
    Sawlwin, D
    Eckhardt, SG
    Holden, SN
    Holden, SN
    [J]. CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6152S - 6152S
  • [19] Phase I study of tanespimycin in combination with bortezomib in patients with advanced solid malignancies
    Schenk, Erin
    Hendrickson, Andrea E. Wahner
    Northfelt, Donald
    Toft, David O.
    Ames, Matthew M.
    Menefee, Michael
    Satele, Daniel
    Qin, Rui
    Erlichman, Charles
    [J]. INVESTIGATIONAL NEW DRUGS, 2013, 31 (05) : 1251 - 1256
  • [20] Phase I and pharmacokinetic study of dasatinib and cetuximab in patients with advanced solid malignancies
    Athanassios Argiris
    Trevor M. Feinstein
    Lin Wang
    Tianbing Yang
    Shruti Agrawal
    Leonard J. Appleman
    Ronald G. Stoller
    Jennifer R. Grandis
    Ann Marie Egloff
    [J]. Investigational New Drugs, 2012, 30 : 1575 - 1584
12345